Atlas Trials

Anthrax AV7909 Boost Evaluation Study

Clinical trial NCT05997264 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05997264
Sponsor
Biomedical Advanced Research and Development Authority
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Anthrax
Start date
2023-12-05
Primary completion
2025-08-28
Enrollment
220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.